Skip to main navigation Skip to search Skip to main content

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

  • Kevin Chung

Press/Media

Period8 Apr 2025

Media coverage

1

Media coverage

  • TitleFDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery
    Media name/outletCardiac Vascular News
    Country/TerritoryUnited States
    Date8/04/25
    URLct.moreover.com/?a=56446870867&p=1gw&v=1&x=Qd6ebzb5qoJYCiugP2mjaQ
    PersonsKevin Chung
View all 1
View less